We are live on ! Find out more
IRD icon

Opus Genetics
IRD

31 hedge funds and large institutions have $4.56M invested in Opus Genetics in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

0.06% less ownership

Funds ownership: 4.92% → 4.85% (-0.06%)

11% less funds holding

Funds holding: 35 → 31 (-4)

17% less capital inflows, than outflows

Capital inflows: $240K | Capital outflows: $290K

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
31
Holders Change
-4
Holders Change %
-11.43%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
8
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$147K
2
Nomura Holdings
Nomura Holdings
Japan
+$32.3K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$22.8K
4
Virtu KCG Holdings
Virtu KCG Holdings
New York
+$20.9K
5
Northern Trust
Northern Trust
Illinois
+$9.5K

Top Sellers

Rank Fund Capital Flow
1
Hudson Valley Investment Advisors
Hudson Valley Investment Advisors
New York
-$122K
2
Bridgeway Capital Management
Bridgeway Capital Management
Texas
-$109K
3
AQR Capital Management
AQR Capital Management
Connecticut
-$22K
4
Goldman Sachs
Goldman Sachs
New York
-$10.9K
5
UBS Group
UBS Group
Switzerland
-$9.5K

IRD Hedge Fund Activity: Q3 2015 in Review

31 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q3 2015, worth a combined $4.56M — down 15% from $5.36M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of IRD and 1 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 8 added.

The largest buyer was Renaissance Technologies, adding an estimated $147K. The largest seller was Hudson Valley Investment Advisors, exiting entirely with an estimated $122K sold.

  • 31 institutional investors held Opus Genetics (IRD) as of Q3 2015, down from 35 in Q2 2015.
  • Funds reported $4.56M of Opus Genetics stock for Q3 2015, down 15% quarter-over-quarter.
  • 1 fund opened new Opus Genetics positions in Q3 2015 and 5 closed out, a net change of -4 holders.
  • The largest Opus Genetics buyer in Q3 2015 was Renaissance Technologies, an estimated $147K added.
  • The largest Opus Genetics seller in Q3 2015 was Hudson Valley Investment Advisors, an estimated $122K sold.

Based on aggregated 13F filings for Q3 2015.